Insider Trading Alert - GNW, WFC, LII, WDR And BMRN Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Dec. 11, 2013, 145 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $117.00 to $353,142,000.00.

Highlighted Stocks Traded by Insiders:

Genworth Financial (GNW) - FREE Research Report

Klein Martin P who is EVP & Chief Financial Officer at Genworth Financial sold 20,000 shares at $15.26 on Dec. 11, 2013. Following this transaction, the EVP & Chief Financial Officer owned 36,439 shares meaning that the stake was reduced by 35.44% with the 20,000-share transaction.

The shares most recently traded at $15.00, down $0.26, or 1.73% since the insider transaction. Historical insider transactions for Genworth Financial go as follows:

  • 24-Week # shares sold: 30,000

The average volume for Genworth Financial has been 8.2 million shares per day over the past 30 days. Genworth Financial has a market cap of $7.6 billion and is part of the financial sector and insurance industry. Shares are up 103.6% year-to-date as of the close of trading on Wednesday.

Genworth Financial, Inc., a financial services company, provides insurance, wealth management, investment, and financial solutions in the United States and internationally. The company's U.S. The stock currently has a dividend yield of 18.84%. The company has a P/E ratio of 13.2. Currently there are 3 analysts that rate Genworth Financial a buy, no analysts rate it a sell, and 6 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on GNW - FREE

TheStreet Quant Ratings rates Genworth Financial as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, impressive record of earnings per share growth, compelling growth in net income, attractive valuation levels and good cash flow from operations. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full Genworth Financial Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Wells Fargo (WFC) - FREE Research Report

Engel Susan E who is Director at Wells Fargo sold 3,887 shares at $44.27 on Dec. 11, 2013. Following this transaction, the Director owned 11,807 shares meaning that the stake was reduced by 24.77% with the 3,887-share transaction.

The shares most recently traded at $43.59, down $0.68, or 1.56% since the insider transaction. Historical insider transactions for Wells Fargo go as follows:

  • 4-Week # shares sold: 6,702
  • 12-Week # shares sold: 6,702
  • 24-Week # shares sold: 170,802

The average volume for Wells Fargo has been 17.8 million shares per day over the past 30 days. Wells Fargo has a market cap of $232.4 billion and is part of the financial sector and banking industry. Shares are up 29.05% year-to-date as of the close of trading on Wednesday.

Wells Fargo & Company provides retail, commercial, and corporate banking services. The stock currently has a dividend yield of 2.72%. The company has a P/E ratio of 11.6. Currently there are 10 analysts that rate Wells Fargo a buy, 1 analyst rates it a sell, and 12 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on WFC - FREE

TheStreet Quant Ratings rates Wells Fargo as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, growth in earnings per share, expanding profit margins, good cash flow from operations and notable return on equity. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full Wells Fargo Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Lennox International (LII) - FREE Research Report

Bluedorn Todd M who is Chairman and CEO at Lennox International sold 6,974 shares at $82.37 on Dec. 11, 2013. Following this transaction, the Chairman and CEO owned 220,176 shares meaning that the stake was reduced by 3.07% with the 6,974-share transaction.

The shares most recently traded at $80.97, down $1.40, or 1.73% since the insider transaction. Historical insider transactions for Lennox International go as follows:

  • 4-Week # shares sold: 7,601
  • 12-Week # shares sold: 10,601
  • 24-Week # shares sold: 42,144

The average volume for Lennox International has been 356,700 shares per day over the past 30 days. Lennox International has a market cap of $4.1 billion and is part of the industrial goods sector and industrial industry. Shares are up 56.3% year-to-date as of the close of trading on Wednesday.

Lennox International Inc., through its subsidiaries, designs, manufactures, and markets climate control products for the heating, ventilation, air conditioning, and refrigeration markets. The stock currently has a dividend yield of 1.17%. The company has a P/E ratio of 24.2. Currently there are 2 analysts that rate Lennox International a buy, 2 analysts rate it a sell, and 6 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on LII - FREE

TheStreet Quant Ratings rates Lennox International as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, impressive record of earnings per share growth, compelling growth in net income, revenue growth and notable return on equity. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full Lennox International Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Waddell & Reed Financial (WDR) - FREE Research Report

Avery Michael L who is President at Waddell & Reed Financial sold 7,500 shares at $63.01 on Dec. 11, 2013. Following this transaction, the President owned 285,580 shares meaning that the stake was reduced by 2.56% with the 7,500-share transaction.

The shares most recently traded at $61.68, down $1.33, or 2.16% since the insider transaction. Historical insider transactions for Waddell & Reed Financial go as follows:

  • 4-Week # shares sold: 7,000
  • 12-Week # shares sold: 20,000
  • 24-Week # shares bought: 61
  • 24-Week # shares sold: 56,540

The average volume for Waddell & Reed Financial has been 648,300 shares per day over the past 30 days. Waddell & Reed Financial has a market cap of $5.4 billion and is part of the financial sector and financial services industry. Shares are up 80.96% year-to-date as of the close of trading on Wednesday.

Waddell & Reed Financial, Inc., through its subsidiaries, provides investment management, investment product underwriting and distribution, and shareholder services administration to mutual funds, and institutional and separately managed accounts in the United States. The stock currently has a dividend yield of 1.78%. The company has a P/E ratio of 23.8. Currently there are 2 analysts that rate Waddell & Reed Financial a buy, 1 analyst rates it a sell, and 6 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on WDR - FREE

TheStreet Quant Ratings rates Waddell & Reed Financial as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, notable return on equity, expanding profit margins, solid stock price performance and impressive record of earnings per share growth. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full Waddell & Reed Financial Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Biomarin Pharmaceutical (BMRN) - FREE Research Report

Lawlis V Bryan who is Director at Biomarin Pharmaceutical sold 2,900 shares at $69.76 on Dec. 11, 2013. Following this transaction, the Director owned 11,400 shares meaning that the stake was reduced by 20.28% with the 2,900-share transaction.

The shares most recently traded at $68.16, down $1.60, or 2.35% since the insider transaction. Historical insider transactions for Biomarin Pharmaceutical go as follows:

  • 4-Week # shares sold: 99
  • 12-Week # shares sold: 99
  • 24-Week # shares sold: 4,165

The average volume for Biomarin Pharmaceutical has been 1.9 million shares per day over the past 30 days. Biomarin Pharmaceutical has a market cap of $9.8 billion and is part of the health care sector and drugs industry. Shares are up 37.87% year-to-date as of the close of trading on Wednesday.

BioMarin Pharmaceutical Inc. develops and commercializes biopharmaceuticals for serious diseases and medical conditions in the United States, Europe, Latin America, and internationally. Currently there are 12 analysts that rate Biomarin Pharmaceutical a buy, no analysts rate it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on BMRN - FREE

TheStreet Quant Ratings rates Biomarin Pharmaceutical as a hold. The company's strengths can be seen in multiple areas, such as its solid stock price performance, revenue growth and largely solid financial position with reasonable debt levels by most measures. However, as a counter to these strengths, we also find weaknesses including feeble growth in the company's earnings per share, deteriorating net income and disappointing return on equity. Get the full Biomarin Pharmaceutical Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Data for this article provided by Zacks Investment Research

null

More from Markets

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

Trump Takes Aim at Auto Imports; Markets End Mixed -- ICYMI

Trump Takes Aim at Auto Imports; Markets End Mixed -- ICYMI

Video: What Oprah's Content Partnership With Apple Means for the Rest of Tech

Video: What Oprah's Content Partnership With Apple Means for the Rest of Tech

REPLAY: Jim Cramer on the Markets, Oil, Starbucks, Tesla, Okta and Red Hat

REPLAY: Jim Cramer on the Markets, Oil, Starbucks, Tesla, Okta and Red Hat

Flashback Friday: The Market Movers

Flashback Friday: The Market Movers